Fusion Pharma
Presence
Fusion Pharma is a company listed under the stock ticker FUSN (CA).
Acquisition, funding and merger involving Fusion Pharma.
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- Fusion Pharma has just announced a $60 Million fundraising (posted on February 16 2023).
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Fusion Pharma
- John Valliant, Chief Executive Officer and Director
- Philina Lee, Director
- Donald Bergstrom, Director
Popular executive movements at Fusion Pharma
- David Meek has joined the company as Director (posted on October 17 2023).
- Teresa Bitetti has joined the company as Director (posted on October 17 2023).
- Jeremy Bender has joined the company as Director (posted on October 17 2023).
Create your alert
to follow the executive moves at Fusion Pharma.
Pharmaceuticals
Fusion Pharma has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Fusion Pharma
Social media about Fusion Pharma
- Fusion Pharma on Wikipedia, Google News & Yahoo Finance
- Fusion Pharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including John Valliant 
Call Fusion Pharma at +1 28...
